Loading...
Invesco Dynamic Biotechnology & Genome ETF
PBE•AMEX
Financial Services
Asset Management
$63.97
$-0.40(-0.63%)
Invesco Dynamic Biotechnology & Genome ETF (PBE) Company Profile & Overview
Explore Invesco Dynamic Biotechnology & Genome ETF’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
Invesco Dynamic Biotechnology & Genome ETF (PBE) Company Profile & Overview
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying intellidex. The underlying intellidex was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.
SectorFinancial Services
IndustryAsset Management
Contact Information
Wheaton, MA
Company Facts
IPO DateJun 23, 2005
CountryUS
Actively Trading